ChemicalBook > CAS DataBase List > 1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea

1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea

Product Name
1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
CAS No.
839713-36-9
Chemical Name
1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
Synonyms
APD125;APD-125;APD 125;RVT-102);Nelotanserin;APD125(Nelotanserin);Nelotanserin (APD-125;APD125;APD-125;APD 125;Nelotanserin, 10 mM in DMSO;APD125; APD-125; APD 125; NELOTANSERIN
CBNumber
CB12484964
Molecular Formula
C18H15BrF2N4O2
Formula Weight
437.24
MOL File
839713-36-9.mol
More
Less

1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea Property

Boiling point:
425.9±45.0 °C(Predicted)
Density 
1.55±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:32.0(Max Conc. mg/mL);73.2(Max Conc. mM)
form 
Solid
pka
12.29±0.70(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

TRC
Product number
N389655
Product name
Nelotanserin
Packaging
5mg
Price
$165
Updated
2021/12/16
TRC
Product number
N389655
Product name
Nelotanserin
Packaging
25mg
Price
$670
Updated
2021/12/16
AK Scientific
Product number
9867CS
Product name
Nelotanserin
Packaging
100mg
Price
$549
Updated
2021/12/16
Biosynth Carbosynth
Product number
FB101032
Product name
1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
Packaging
50mg
Price
$231
Updated
2021/12/16
ChemScene
Product number
CS-5984
Product name
Nelotanserin
Purity
99.79%
Packaging
25mg
Price
$250
Updated
2021/12/16
More
Less

1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea Chemical Properties,Usage,Production

Uses

Nelotanserin is a potent selective 5-HT2A inverse agonist, nelotanserin has low nanomolar potency on the 5-HT2A receptor with at least 30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.

Definition

ChEBI: Nelotanserin is a member of pyrazoles and a ring assembly.

Synthesis

720702-45-4

59025-55-7

839713-36-9

3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyaniline (16.7 kg) was dissolved in acetonitrile (78.6 kg) in a 200 liter glass jacketed reactor under nitrogen protection. Top stirring was turned on and the internal temperature was controlled within the specified range. Subsequently, 2,4-difluorophenyl isocyanate was slowly added to keep the temperature of the reaction system stable. Upon completion of the reaction, the target product 1-(3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl)-3-(2,4-difluorophenyl)urea was isolated and purified by appropriate post-treatment steps.

in vivo

Each compound is tested in a minimum of five rats by oral gavage with administration occurring in the middle of the inactive period, 6 h after light onset. The delta power during non-REM sleep (NREMS) is significantly different between all the analogues tested and the vehicle control. Nelotanserin (Compound 39) produces significant increases in delta power that persist for the first 4 h following dosing. Significant differences are found, however, in NREMS bout length. Nelotanserin significantly increases NREMS bout length during the first hour following dosing, and 3 does so during the second hour. In conjunction with this increased NREM bout duration, the number of NREM bouts decrease during the first hour for Nelotanserin (p<0.01) as well as for compound 15 (p<0.05)[2].

IC 50

5-HT2A Receptor: 1.7 nM (IC50); 5-HT2C Receptor: 79 nM (IC50); 5-HT2B Receptor: 791 nM (IC50)

References

[1] Patent: US2016/67216, 2016, A1. Location in patent: Paragraph 0834; 0835
[2] Patent: WO2010/62321, 2010, A1. Location in patent: Page/Page column 75-76
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 5, p. 1923 - 1936
[4] Patent: WO2006/81335, 2006, A2. Location in patent: Page/Page column 34-37

1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea Suppliers

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
Deyang Yuehe Bio-Pharmaceutical Co.,Ltd
Tel
028-82729560 18030702676
Fax
028-82729560
Email
sales@yuehepharm.com
Country
China
ProdList
179
Advantage
58
Shanghai Balmxy Pharmaceutical Co., Ltd
Tel
021-24206007 13764915196
Fax
86-021-23027023
Email
sales@balmxy.com
Country
China
ProdList
6874
Advantage
55
Shanghai HuanChuan Industry Co.,Ltd.
Tel
021-61478794
Fax
021-61478794
Email
sales@hcshhai.com
Country
China
ProdList
9793
Advantage
50
SanoChem (Chengdu) Tech. Co., Ltd.
Tel
28-87999436 02887999436
Fax
QQ:2746983436
Email
sales@sano-chem.com
Country
China
ProdList
3795
Advantage
55
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2990
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Chengdu Focus Pharmaceutical Technology Co., Ltd.
Tel
028-64950838 17340131597
Email
bd-focus@focuspharm.com
Country
China
ProdList
850
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
Wuhan Sun-shine Bio-technology Corporation Limited
Tel
+86-027-6552-2453
Email
sales@sun-shinechem.com
Country
China
ProdList
727
Advantage
58

839713-36-9, 1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)ureaRelated Search:


  • APD125(Nelotanserin)
  • APD 125
  • APD125
  • APD-125
  • APD125;APD-125;APD 125
  • 1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
  • Urea, N-[3-(4-broMo-1-Methyl-1H-pyrazol-5-yl)-4-Methoxyphenyl]-N'-(2,4-difluorophenyl)-
  • Nelotanserin
  • 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
  • APD125; APD-125; APD 125; NELOTANSERIN
  • 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
  • 5-HT Receptor,Inhibitor,APD 125,inhibit,APD-125,Nelotanserin,Serotonin Receptor,5-hydroxytryptamine Receptor
  • Nelotanserin, 10 mM in DMSO
  • Nelotanserin (APD-125
  • RVT-102)
  • 839713-36-9